Yuslina Mat Yusoff

Hsa-miR-181a-5p, hsa-miR-182-5p, and hsa-miR-26a-5p as potential biomarkers for BCR-ABL1 among adult chronic myeloid leukemia treated with tyrosine kinase inhibitors at the molecular response

K. Chang, N. Muhamad, Aliza Mohd Yacob, 2022, BMC Cancer.

Characterization of New Alpha Zero (α0) Thalassaemia Deletion (−−GB) among Malays in Malaysian Population

E. Esa, S. Hassan, F. S. Abdul Hamid, 2023, Diagnostics.

Construction of a microRNA-mRNA Regulatory Network in De Novo Cytogenetically Normal Acute Myeloid Leukemia Patients.

K. Chang, S. Zain, Z. Zakaria, 2021, Genetic testing and molecular biomarkers.